A provider that exits the market leaves you scrambling for continuity of care
Adiponectin is one of the most abundant adipokines secreted by WAT and enhances insulin sensitivity [78,79,80]
They will evaluate your situation and determine if any adjustments to your medication regimen are necessary
Others respond better to tirzepatide
For many people, non-GLP-1 medications, alone or in combination, can produce meaningful, sustainable results when chosen thoughtfully
Healthcare providers may consider: Bacterial culture if infection is suspected Temporary discontinuation of semaglutide to assess symptom resolution Referral to allergy/immunology for suspected hypersensitivity reactions For type 2 diabetes patients only, alternative GLP-1 receptor agonist formulations (such as oral semaglutide/Rybelsus) if injection site reactions are recurrent and problematic Patients with confirmed hypersensitivity to semaglutide should not continue the medication